These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23666756)

  • 1. Kallistatin antagonizes Wnt/β-catenin signaling and cancer cell motility via binding to low-density lipoprotein receptor-related protein 6.
    Zhang J; Yang Z; Li P; Bledsoe G; Chao L; Chao J
    Mol Cell Biochem; 2013 Jul; 379(1-2):295-301. PubMed ID: 23666756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rottlerin induces Wnt co-receptor LRP6 degradation and suppresses both Wnt/β-catenin and mTORC1 signaling in prostate and breast cancer cells.
    Lu W; Lin C; Li Y
    Cell Signal; 2014 Jun; 26(6):1303-9. PubMed ID: 24607787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis.
    Li P; Guo Y; Bledsoe G; Yang Z; Chao L; Chao J
    Exp Cell Res; 2016 Jan; 340(2):305-14. PubMed ID: 26790955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway.
    Lu W; Lin C; Roberts MJ; Waud WR; Piazza GA; Li Y
    PLoS One; 2011; 6(12):e29290. PubMed ID: 22195040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cripto-1 enhances the canonical Wnt/β-catenin signaling pathway by binding to LRP5 and LRP6 co-receptors.
    Nagaoka T; Karasawa H; Turbyville T; Rangel MC; Castro NP; Gonzales M; Baker A; Seno M; Lockett S; Greer YE; Rubin JS; Salomon DS; Bianco C
    Cell Signal; 2013 Jan; 25(1):178-89. PubMed ID: 23022962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ACBP suppresses the proliferation, migration, and invasion of colorectal cancer via targeting Wnt/beta-catenin signaling pathway.
    Tong X; Zhuang Z; Wang X; Yang X; Bai L; Su L; Wei P; Su X
    Biomed Pharmacother; 2021 May; 137():111209. PubMed ID: 33581651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane protein 97 exhibits oncogenic properties via enhancing LRP6-mediated Wnt signaling in breast cancer.
    Zhu H; Su Z; Ning J; Zhou L; Tan L; Sayed S; Song J; Wang Z; Li H; Sun Q; Liu S; Sha O; Leng F; Chen X; Lu D
    Cell Death Dis; 2021 Oct; 12(10):912. PubMed ID: 34615853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiangiogenic and antineuroinflammatory effects of kallistatin through interactions with the canonical Wnt pathway.
    Liu X; Zhang B; McBride JD; Zhou K; Lee K; Zhou Y; Liu Z; Ma JX
    Diabetes; 2013 Dec; 62(12):4228-38. PubMed ID: 23884893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallistatin as an inhibitory protein against colorectal cancer cells through binding to LRP6.
    Shahbazi B; Mafakher L; Arab SS; Teimoori-Toolabi L
    J Biomol Struct Dyn; 2024; 42(2):918-934. PubMed ID: 37114408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VSTM2A suppresses colorectal cancer and antagonizes Wnt signaling receptor LRP6.
    Dong Y; Zhang Y; Kang W; Wang G; Chen H; Higashimori A; Nakatsu G; Go M; Tong JH; Zheng S; To KF; Sung JJ; Yang X; Ng SS; Yu J
    Theranostics; 2019; 9(22):6517-6531. PubMed ID: 31588233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells.
    Wang Z; Li B; Zhou L; Yu S; Su Z; Song J; Sun Q; Sha O; Wang X; Jiang W; Willert K; Wei L; Carson DA; Lu D
    Proc Natl Acad Sci U S A; 2016 Nov; 113(46):13150-13155. PubMed ID: 27799526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gigantol inhibits Wnt/β-catenin signaling and exhibits anticancer activity in breast cancer cells.
    Yu S; Wang Z; Su Z; Song J; Zhou L; Sun Q; Liu S; Li S; Li Y; Wang M; Zhang GQ; Zhang X; Liu ZJ; Lu D
    BMC Complement Altern Med; 2018 Feb; 18(1):59. PubMed ID: 29444668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DKK1 Activates the PI3K/AKT Pathway via CKAP4 to Balance the Inhibitory Effect on Wnt/β-Catenin Signaling and Regulates Wnt3a-Induced MSC Migration.
    Chen H; Hu Y; Xu X; Dai Y; Qian H; Yang X; Liu J; He Q; Zhang H
    Stem Cells; 2024 Jun; 42(6):567-579. PubMed ID: 38469899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells.
    Lu W; Li Y
    J Cell Biochem; 2014 Oct; 115(10):1799-807. PubMed ID: 24905570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
    Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pantoprazole on human gastric adenocarcinoma SGC7901 cells through regulation of phospho‑LRP6 expression in Wnt/β-catenin signaling.
    Shen W; Zou X; Chen M; Shen Y; Huang S; Guo H; Zhang L; Liu P
    Oncol Rep; 2013 Aug; 30(2):851-5. PubMed ID: 23754096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
    Lu W; Lin C; King TD; Chen H; Reynolds RC; Li Y
    Cell Signal; 2012 Dec; 24(12):2291-6. PubMed ID: 22820499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-arrestin promotes Wnt-induced low density lipoprotein receptor-related protein 6 (Lrp6) phosphorylation via increased membrane recruitment of Amer1 protein.
    Kríz V; Pospíchalová V; Masek J; Kilander MB; Slavík J; Tanneberger K; Schulte G; Machala M; Kozubík A; Behrens J; Bryja V
    J Biol Chem; 2014 Jan; 289(2):1128-41. PubMed ID: 24265322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Wnt Co-Receptor LRP6 in Triple Negative Breast Cancer Cell Migration and Invasion.
    Ma J; Lu W; Chen D; Xu B; Li Y
    J Cell Biochem; 2017 Sep; 118(9):2968-2976. PubMed ID: 28247948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
    Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
    Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.